These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 31852267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF, Jia ZY, Yang ZQ, Fan WL, Shi HB.
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
    [Abstract] [Full Text] [Related]

  • 3. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis.
    Yang Y, Yu H, Qi L, Liu C, Feng Y, Qi J, Li J, Zhu Q.
    Int J Hyperthermia; 2022 Nov; 39(1):455-465. PubMed ID: 35271786
    [Abstract] [Full Text] [Related]

  • 4. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR, Cristescu MM, Hinshaw A, Woo KM, Wells SA, Ziemlewicz TJ, Lubner MG, Dalvie PS, Louis Hinshaw J, Brace CL, Ozkan OS, Lee FT, Laeseke P.
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L, Li HL, Guo CY, Luo SX.
    Korean J Radiol; 2018 Sep; 19(2):237-246. PubMed ID: 29520181
    [Abstract] [Full Text] [Related]

  • 6. Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.
    Zhang R, Shen L, Zhao L, Guan Z, Chen Q, Li W.
    Diagn Interv Radiol; 2018 Jul; 24(4):219-224. PubMed ID: 29792289
    [Abstract] [Full Text] [Related]

  • 7. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C, Shen L, Qiu Z, Qi H, Cao F, Xie L, Fan W.
    J Cancer Res Ther; 2020 Jul; 16(2):250-257. PubMed ID: 32474509
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study.
    Biederman DM, Titano JJ, Bishay VL, Durrani RJ, Dayan E, Tabori N, Patel RS, Nowakowski FS, Fischman AM, Kim E.
    Radiology; 2017 Jun; 283(3):895-905. PubMed ID: 27930089
    [Abstract] [Full Text] [Related]

  • 10. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X, Chen B, An C, Cheng Z, Han Z, Liu F, Yu J, Liang P.
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [Abstract] [Full Text] [Related]

  • 11. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
    Thornton LM, Cabrera R, Kapp M, Lazarowicz M, Vogel JD, Toskich BB.
    Curr Probl Diagn Radiol; 2017 Sep; 46(6):402-409. PubMed ID: 28392205
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
    Huang ZM, Lai CX, Zuo MX, An C, Wang XC, Huang JH, Ning E.
    J Cancer Res Ther; 2020 Sep; 16(7):1603-1610. PubMed ID: 33565506
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY, Fang ZT, Sun HL, An C, Huang ZM, Zhang TQ, Jiang XY, Chen YT, Xu LF, Huang JH.
    Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
    [Abstract] [Full Text] [Related]

  • 15. Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCC.
    Iezzi R, Posa A, Tanzilli A, Carchesio F, Pompili M, Manfredi R.
    Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1702-1707. PubMed ID: 32676963
    [Abstract] [Full Text] [Related]

  • 16. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
    Xu Z, Xie H, Zhou L, Chen X, Zheng S.
    Anal Cell Pathol (Amst); 2019 Nov; 2019():8619096. PubMed ID: 31534899
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma.
    Li Z, Jiao D, Han X, Si G, Li Y, Liu J, Xu Y, Zheng B, Zhang X.
    Cancer Imaging; 2020 Jan 30; 20(1):13. PubMed ID: 32000862
    [Abstract] [Full Text] [Related]

  • 19. Comparison of combined transarterial chemoembolization and ablations in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Keshavarz P, Raman SS.
    Abdom Radiol (NY); 2022 Mar 30; 47(3):1009-1023. PubMed ID: 34982183
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF.
    World J Gastroenterol; 2014 Dec 14; 20(46):17483-90. PubMed ID: 25516662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.